Dublin, Dec. 23, 2016 -- Research and Markets has announced the addition of the "Advanced Wound Care and Closure Market Analysis & Trends - Product (Active Wound Care, Surgical Wound Care, Infection Management and Therapy Devices), Application (Chronic Wound Care and Acute Wound Care) - Forecast to 2025" report to their offering.
Some of the prominent trends that the market is witnessing include increasing funding in wound care and development, rising geriatic population and impetus growth of disorders , increasing volume of surgeries across the globe, recent technological advancements in Advanced Wound Care and Closure, and growth opportunities/investment opportunities.
Based on End-User the market is categorized into hospitals & specialty wound clinics, and home healthcare. Further is segmented into inpatient settings and long-term care facilities. Application segment is segregated into chronic wound care, acute wound care, and other applications. Chronic wound care is simultaneously sub-divided into arterial ulcers, diabetic foot ulcers, venous leg ulcers, pressure ulcers, and other chronic wounds moreover; acute wound care is sub-divided into burns and surgical & traumatic wounds.
Depending on products the market is categorized into active wound care, advanced wound dressings, surgical wound care, infection management, therapy devices, traditional/basic wound care, and other products.
This industry report analyzes the global markets for Advanced Wound Care and Closure across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
4 Advanced Wound Care and Closure Market, By End-User
5 Advanced Wound Care and Closure Market, By Application
6 Advanced Wound Care and Closure Market, By Product
6.6 Traditional/Basic wound care
7 Advanced Wound Care and Closure Market, By Geography
8 Key Player Activities
9 Leading Companies
- 3M Company
- Acelity L.P. Inc.
- Alliqua BioMedical, Inc.
- BSN Medical GmbH
- Baxter International Inc.
- Coloplast A/S
- Convatec Healthcare B S.À.R.L.
- Covidien PLC (A Subsidiary of Medtronic Company)
- Derma Sciences,Inc
- Ethicon, Inc.
- Holdings Corporation
- Integra LifeSciences
- Kinetic Concepts
- Medtronic plc
- Mölnlycke Health Care AB
- Smith & Nephew PLC
For more information about this report visit http://www.researchandmarkets.com/research/pjvn4j/advanced_wound
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Wound Care , Surgical Devices


Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



